BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24320881)

  • 21. Long-term sustained release of salicylic acid from cross-linked biodegradable polyester induces a reduced foreign body response in mice.
    Chandorkar Y; Bhaskar N; Madras G; Basu B
    Biomacromolecules; 2015 Feb; 16(2):636-49. PubMed ID: 25559641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase-sensitive polymer-based controlled delivery systems of leuprolide acetate: in vitro release, biocompatibility, and in vivo absorption in rabbits.
    Singh S; Singh J
    Int J Pharm; 2007 Jan; 328(1):42-8. PubMed ID: 16959451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(D,L-lactide-ran-epsilon-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-ran-epsilon-caprolactone) as parenteral drug-delivery systems.
    Cho H; Chung D; Jeongho A
    Biomaterials; 2004 Aug; 25(17):3733-42. PubMed ID: 15020149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
    Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
    Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.
    Papadimitriou S; Bikiaris D
    J Control Release; 2009 Sep; 138(2):177-84. PubMed ID: 19446585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo behavior of poly(1,3-trimethylene carbonate) and copolymers of 1,3-trimethylene carbonate with D,L-lactide or epsilon-caprolactone: Degradation and tissue response.
    Pêgo AP; Van Luyn MJ; Brouwer LA; van Wachem PB; Poot AA; Grijpma DW; Feijen J
    J Biomed Mater Res A; 2003 Dec; 67(3):1044-54. PubMed ID: 14613255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodegradable polyesters for controlled release of trypanocidal drugs: in vitro and in vivo studies.
    Lemmouchi Y; Schacht E; Kageruka P; De Deken R; Diarra B; Diall O; Geerts S
    Biomaterials; 1998 Oct; 19(20):1827-37. PubMed ID: 9855183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems.
    Patel RB; Carlson AN; Solorio L; Exner AA
    J Biomed Mater Res A; 2010 Aug; 94(2):476-84. PubMed ID: 20186771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PLA/F68/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study.
    Li D; Guo G; Fan R; Liang J; Deng X; Luo F; Qian Z
    Int J Pharm; 2013 Jan; 441(1-2):365-72. PubMed ID: 23178216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermosensitive β-cyclodextrin modified poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) micelles prolong the anti-inflammatory effect of indomethacin following local injection.
    Wei X; Lv X; Zhao Q; Qiu L
    Acta Biomater; 2013 Jun; 9(6):6953-63. PubMed ID: 23416577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Star-shaped polyester-based elastomers as an implantable delivery system for insulin: Development, pharmacokinetics, pharmacodynamics, and biocompatibility.
    Guo F; Huang D; Zhang W; Yan Q; Yang Q; Yang Y; Li H; Yun J; Hong W; Yang G
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():180-187. PubMed ID: 29519427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term Local and Systemic Safety of Poly(L-lactide-co-epsilon-caprolactone) after Subcutaneous and Intra-articular Implantation in Rats.
    Ramot Y; Nyska A; Markovitz E; Dekel A; Klaiman G; Zada MH; Domb AJ; Maronpot RR
    Toxicol Pathol; 2015 Dec; 43(8):1127-40. PubMed ID: 26296630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlling protein release from scaffolds using polymer blends and composites.
    Ginty PJ; Barry JJ; White LJ; Howdle SM; Shakesheff KM
    Eur J Pharm Biopharm; 2008 Jan; 68(1):82-9. PubMed ID: 17884400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
    Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Kaseem A; Nutan MT; Hussain MD
    J Pharm Sci; 2012 Oct; 101(10):3753-62. PubMed ID: 22753324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone-loaded poly(epsilon-caprolactone) intravitreal implants: a pilot study.
    Fialho SL; Behar-Cohen F; Silva-Cunha A
    Eur J Pharm Biopharm; 2008 Mar; 68(3):637-46. PubMed ID: 17851057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute toxicity evaluation of in situ gel-forming controlled drug delivery system based on biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Fang F; Gong CY; Dong PW; Fu SZ; Gu YC; Guo G; Zhao X; Wei YQ; Qian ZY
    Biomed Mater; 2009 Apr; 4(2):025002. PubMed ID: 19208940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.
    Xiong XB; Uludağ H; Lavasanifar A
    Biomaterials; 2009 Jan; 30(2):242-53. PubMed ID: 18838158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of polymer composition on rheological and degradation properties of temperature-responsive gelling systems composed of acyl-capped PCLA-PEG-PCLA.
    Petit A; Müller B; Meijboom R; Bruin P; van de Manakker F; Versluijs-Helder M; de Leede LG; Doornbos A; Landin M; Hennink WE; Vermonden T
    Biomacromolecules; 2013 Sep; 14(9):3172-82. PubMed ID: 23875877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis.
    Sung HJ; Meredith C; Johnson C; Galis ZS
    Biomaterials; 2004 Nov; 25(26):5735-42. PubMed ID: 15147819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
    Packhaeuser CB; Kissel T
    J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.